申请人:Neurogen Corporation
公开号:US05723462A1
公开(公告)日:1998-03-03
Disclosed are compounds of formula I: ##STR1## wherein R.sub.8 and R.sub.9 independently represent hydrogen or organic substituents; W represents optionally substituted thiazolyl or quinoxalinyl; X is hydrogen, hydroxy or lower alkyl; and T is hydrogen, halogen, hydroxy, nitro, amino or alkyl, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptor. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.
化合物的结构式为I:##STR1## 其中R.sub.8和R.sub.9独立地代表氢或有机取代基;W代表可选择取代的噻唑基或喹喔啉基;X为氢、羟基或低碳基;T为氢、卤素、羟基、硝基、氨基或烷基,这些化合物是GABAa脑受体的高选择性激动剂、拮抗剂或逆拮抗剂,或者是GABAa脑受体激动剂、拮抗剂或逆拮抗剂的前药。这些化合物在焦虑、睡眠和癫痫障碍、苯二氮卓类药物过量和增强记忆的诊断和治疗中很有用。